Clinical Trial Update: Study to Evaluate the Long Term Safety and Efficacy of DWP16001 in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial is evaluating the long-term safety and efficacy of DWP16001 in patients with type 2 diabetes mellitus; status is currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• DWP16001

Snippet

Sponsor: Daewoong Pharmaceutical Co. LTD. | Conditions: T2DM (Type 2 Diabetes Mellitus) | Phase 3 | Status: UNKNOWN